Mobile Health Intervention for Active Tuberculosis

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

April 9, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

July 31, 2020

Conditions
TuberculosisAdherence, Medication
Interventions
BEHAVIORAL

Mobile phone TB treatment support app plus usual care

The behavioral intervention is delivered through a mobile phone TB support app. The functions allow the participant to: self-report daily administration of their TB medication, self-report side effects if applicable, review educational material on TB disease and its treatment, complete a treatment adherence monitoring test (urine drug metabolite test), take notes, and review their treatment progress/report. The drug metabolite test will require that the participant place a small amount of urine on the end of the paper strip, wait for results, and take a picture of the paper using the app. The purpose of this test is to confirm that medication was correctly taken within the past 24 hours.

OTHER

Usual care

Usual care consists of outpatient treatment management from the time of diagnosis (unless symptoms are severe and hospitalization is recommended), routine clinical and laboratory tests, and follow-up appointments determined by the clinician. In general, patients receive 1-2 month's supply of medication and are asked to return monthly for follow-up.

Trial Locations (1)

1602

Hospital Dr. Antonio A. Cetrángolo, Vicente López

All Listed Sponsors
collaborator

National Institute of Nursing Research (NINR)

NIH

lead

University of Washington

OTHER

NCT03544476 - Mobile Health Intervention for Active Tuberculosis | Biotech Hunter | Biotech Hunter